Anteris Technologies Global Corp. — Director's Dealing 2009

Apr 6, 2009

==> picture [595 x 64] intentionally omitted <==

Innovative BioMedical Devices

Level 11, 225 St Georges Terrace Telephone (08) 9262 6777 bioMD Limited ABN 35 088 221 078 Facsimile (08) 9322 3433 Perth, Western Australia 6000 PO Box 7209, Cloisters Square www.biomd.com.au Western Australia 6850

ANNOUNCEMENT TO THE AUSTRALIAN STOCK EXCHANGE

1 of 4 pages

7 April 2009

Company Announcements Office Australian Stock Exchange Limited 10[th] Floor, 20 Bond Street SYDNEY NSW 2000

Dear Sir/Madam

Re: Appendix 3Y – Change in Director’s Interest Notice

The Directors of bioMD Ltd wish to advise of changes to the notifiable interests of directors in accordance with Listing Rule 3.19A.1 and section 205G of the Corporations Act.

Please refer to the ‘Appendix 3Y’ attached for details of the change in holding as a result of the allotment of shares under the recent rights issue to eligible shareholders.

Yours faithfully

==> picture [78 x 59] intentionally omitted <==

Caroline Bentley Company Secretary

==> picture [595 x 42] intentionally omitted <==

APPENDIX 3Y

CHANGE OF DIRECTOR’S INTEREST NOTICE

Name of Entity: bioMD Limited ABN: 35 055 221 078

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director: Robert Towner Date of last notice: 29 January 2009

PART 1 – Change of director's relevant interests in securities

Direct or indirect interest: Direct / Indirect Nature of indirect interest: Mr Towner is a director of a company holding BOD Date of change: 6 April 2009 No. of securities held prior to change: Ordinary shares–11,321,328 (indirect), 420,000 (direct) Class: Listed ordinary shares (BOD) Number acquired: 5,660,664 shares (indirect) and 210,000 (direct) Number disposed: Nil Value/Consideration: $117,413 No. of securities held after change: Ordinary shares–16,981,992 (indirect) and 630,000 (direct) Nature of the change: Rights issue PART 2 – Change of director’s interests in contracts Details of contract: None Applicable Nature of interest: Name of registered holder: (if issued securities) No. and class of securities to which interest relates: Interest acquired: Interest disposed: Value/Consideration: Interest after change:

APPENDIX 3Y CHANGE OF DIRECTOR’S INTEREST NOTICE

Name of Entity: bioMD Limited ABN: 35 055 221 078 We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director:	Robert Scott
Date of last notice:	14 December 2007
PART 1– Change of director's relevant interests in securities
Direct or indirect interest:	Direct / Indirect
Nature of indirect interest:	Mr Scott is a director of a company holding BOD
Date of change:	6 April 2009
**No. of securities held prior to change: **Ordinary shares–390,750 (indirect)
Class:	Listed ordinary shares (BOD)
Number acquired:	195,375 shares (indirect)
Number disposed:	Nil
Value/Consideration:	$3,907
No. of securities held after change:	Ordinary shares–586,125 (indirect)
Nature of the change:	Rights issue
PART 2– Change of director’s interests in contracts
Details of contract:	None Applicable
Nature of interest:
Name of registered holder:
(if issued securities)
No. and class of securities to which interest relates:
Interest acquired:
Interest disposed:
Value/Consideration:
Interest after change:

APPENDIX 3Y CHANGE OF DIRECTOR’S INTEREST NOTICE

Name of Entity:

ABN:

bioMD Limited

35 055 221 078

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director: Michael Bennett Date of last notice: 20 December 2007

PART 1 – Change of director's relevant interests in securities

Direct or indirect interest: Direct / Indirect Nature of indirect interest: Mr Bennett is a director of a company holding BOD Date of change: 6 April 2009 No. of securities held prior to change: Ordinary shares–8,070,000 (indirect), 100,000 (direct) Class: Listed ordinary shares (BOD) Number acquired: 1,550,000 shares (indirect) Number disposed: Nil Value/Consideration: $31,000 No. of securities held after change: Ordinary shares–9,620,000 (indirect), 100,000 (direct) Nature of the change: Rights issue PART 2 – Change of director’s interests in contracts Details of contract: None Applicable Nature of interest: Name of registered holder: (if issued securities) No. and class of securities to which interest relates: Interest acquired: Interest disposed: Value/Consideration: Interest after change: